14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This review examines the pharmacokinetics, modes of action and therapeutic properties of the anti-malarial drugs, hydroxychloroquine (HCQ) and chloroquine (CQ), in the treatment of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and related conditions, as well as osteoarthritis (OA).

          Related collections

          Author and article information

          Journal
          Inflammopharmacology
          Inflammopharmacology
          Springer Nature
          1568-5608
          0925-4692
          Oct 2015
          : 23
          : 5
          Affiliations
          [1 ] Biomedical Research Centre, Sheffield Hallam University, Howard Street, Sheffield, S1 1WB, UK.
          [2 ] Department of Rheumatology, St Francis Hospital and Medical Center, Hartford, CT, 06105, USA.
          [3 ] McMaster University, Hamilton, ON, L8S 4K9, Canada.
          [4 ] Department of Medicine (Rheumatology), McMaster University Faculty of Health Sciences, Hamilton, ON, L8S 4K9, Canada. keanmac@cogeco.ca.
          [5 ] Department of Medicine (Rheumatology), McMaster University Faculty of Health Sciences, Suite #708, 1 Young Street, Hamilton, ON, L8N 1T8, Canada. keanmac@cogeco.ca.
          Article
          10.1007/s10787-015-0239-y
          10.1007/s10787-015-0239-y
          26246395
          671ac997-cf2f-42c2-8ac6-3d7a88d50685
          History

          Chloroquine,Chronic inflammation,Cytokine,Dermatological,Hydroxychloroquine,Inflammasome,Lupus,Lysosomotropic activity,Rheumatoid arthritis,Sjøgren’s syndrome,Toll-like receptors

          Comments

          Comment on this article